Comparison of Bevacizumab Quantification Results in Plasma of Non-small Cell Lung Cancer Patients Using Bioanalytical Techniques Between LC-MS/MS, ELISA, and Microfluidic-based Immunoassay

Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors

Xiaochen Zhao, Satyendra Suryawanshi, Matthew Hruska et al. · Annals of Oncology · 2017 · 235 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Simultaneous Multiple Immunoassays in a Compact Disc–Shaped Microfluidic Device Based on Centrifugal Force

N. Honda, Ulrika Lindberg, Per Andersson et al. · Clinical Chemistry · 2005 · 155 citations

Engineering, Bioengineering, Biomedical Engineering +17

IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions

Chang‐Han Lee, Gabrielle Romain, Wupeng Yan et al. · Nature Immunology · 2017 · 150 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

LC−MS/MS Approach for Quantification of Therapeutic Proteins in Plasma Using a Protein Internal Standard and 2D-Solid-Phase Extraction Cleanup

Ziping Yang, Michael Hayes, Xinping Fang et al. · Analytical Chemistry · 2007 · 136 citations

Pharmacy, Biochemistry, Pharmaceutical Analysis +17

A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors

Francesco Atzori, Josep Tabernero, Andrés Cervantes et al. · Clinical Cancer Research · 2011 · 121 citations · Full text

Medicine, Oncology, Pharmacology +17